Schelch, K.
17  results:
Search for persons X
?
 
?
4

EP14.02-006 Subtype-specific Hypersensitivity to Oxidative ..:

Boettiger, K. ; Schwendenwein, A. ; Lang, C....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S539-S540 , 2022
 
?
5

EP07.02-001 Evaluation of FGF18 as a Contributing Factor in..:

Mosleh, B. ; Schelch, K. ; Klikovits, T....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S325-S326 , 2022
 
?
6

EP07.01-014 Mesothelioma-Associated Fibroblasts Enhance Mes..:

Ries, A. ; Flehberger, D. ; Schelch, K....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S319 , 2022
 
?
7

EP14.02-003 Clinical Significance of MYC Family Members in ..:

Lang, C. ; Lantos, A. ; Megyesfalvi, Z....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S537-S538 , 2022
 
?
9

Proteomic analysis of brain metastatic lung adenocarcinoma ..:

Woldmar, N ; Schwendenwein, A ; Kuras, M...
https://research.rug.nl/en/publications/1fba2fac-ce2a-4d40-8d04-2a9056a1ef73.  , 2023
 
?
10

Clinical and prognostic implications of CD47 and PD-L1 expr..:

Lang, C ; Lantos, A ; Megyesfalvi, Z...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808447/.  , 2022
 
?
11

ESMO Open / Clinical and prognostic implications of CD47 an..:

Dome, B ; Lang, C ; Lantos, A...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-63468/128.  , 2022
 
?
12

Proteomic analysis of brain metastatic lung adenocarcinoma ..:

Woldmar, N ; Schwendenwein, A ; Kuras, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024110/.  , 2022
 
?
 
1-15